Novartis AG's growth products as percent of pharma revenue 2009-2016

Contribution of Novartis AG's growth products to pharmaceutical revenue from 2009 to 2016*

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

January 2017

Region

Worldwide

Survey time period

2009 to 2016

Supplementary notes

* Novartis Pharmaceuticals division. Growth products are defined as products launched since 2009 or later, or with exclusivity until at least the next four years in key markets (EU, US, Japan).
** With the 2015 Annual Report, values back to 2011 were restated, as a result of a series of transactions during 2015.
This statistic was assembled from several editions of the Novartis annual report.

Open this statistic in...
Citation formats
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 USD $39 USD / Month *
in the first 12 months
Professional Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on " Pharmaceutical market worldwide "

Statistics on Pharmaceutical market worldwide

Overview

7

Segments

8

Companies

8

R&D, patents, new products

8

Outlook

7

Focus: COVID-19 response

7

Further related statistics

19
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Learn more about how Statista can support your business.